Cargando…
抑制Src酪氨酸激酶活性对人肺癌A549/DDP细胞耐药性及MDR1和LRP表达的影响
BACKGROUND AND OBJECTIVE: The aim of this study is to investigate the effect of Src tyrosine kinase inhibition on the drug-resistance as well as the expression of multidrug resistance 1 (MDR1) and lung resistance-related protein (LRP) of the human cis-platinum-resistant lung cancer cell line A549/DD...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999856/ https://www.ncbi.nlm.nih.gov/pubmed/22989452 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.09.01 |
Ejemplares similares
-
酪氨酸激酶抑制剂耐药机制及其治疗策略
Publicado: (2011) -
抑制Src酪氨酸激酶对非小细胞肺癌细胞分泌MMP-2和MMP-9的影响
Publicado: (2011) -
RNA干扰ERCC1基因表达对肺腺癌细胞A549/DDP顺铂耐药的影响
Publicado: (2010) -
BCR-ABL激酶区突变在酪氨酸激酶抑制剂耐药慢性髓性白血病患者中的分布及其影响因素
Publicado: (2020) -
RNA干扰GRP75表达改善人肺腺癌细胞对顺铂耐药性
Publicado: (2011)